ZA200201819B - Preventive and therapeutic agents for eye diseases. - Google Patents

Preventive and therapeutic agents for eye diseases.

Info

Publication number: ZA200201819B
Authority: ZA; South Africa
Prior art keywords: preventive; therapeutic agents; eye diseases; diseases; eye
Prior art date: 1999-09-06

Application number

ZA200201819A

Other languages

English (en)

Inventor

Hiroaki Naka

Kazuhito Kawabata

Hideki Tokushige

Original Assignee

Ono Pharmaceutical Co

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-06

Filing date

2002-03-05

Publication date

2003-05-28

2002-03-05 Application filed by Ono Pharmaceutical Co, Senju Pharma Co filed Critical Ono Pharmaceutical Co

2003-05-28 Publication of ZA200201819B publication Critical patent/ZA200201819B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200201819A 1999-09-06 2002-03-05 Preventive and therapeutic agents for eye diseases. ZA200201819B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP25153899		1999-09-06

Publications (1)

Publication Number	Publication Date
ZA200201819B true ZA200201819B (en)	2003-05-28

Family

ID=17224318

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200201819A ZA200201819B (en)	1999-09-06	2002-03-05	Preventive and therapeutic agents for eye diseases.

Country Status (14)

Country	Link
US (1)	US6624193B1 (fr)
EP (1)	EP1213018A4 (fr)
JP (1)	JP4682495B2 (fr)
KR (1)	KR20020042667A (fr)
CN (1)	CN1387436A (fr)
AU (1)	AU6870800A (fr)
BR (1)	BR0013793A (fr)
CA (1)	CA2383971A1 (fr)
HU (1)	HUP0202745A2 (fr)
MX (1)	MXPA02002452A (fr)
NO (1)	NO20021094L (fr)
NZ (1)	NZ517556A (fr)
WO (1)	WO2001017527A1 (fr)
ZA (1)	ZA200201819B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6552082B2 (en) *	2000-06-29	2003-04-22	Ono Pharmaceutical Co., Ltd.	Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
JP5000835B2 (ja) *	2000-08-25	2012-08-15	千寿製薬株式会社	水性懸濁液剤
US7315848B2 (en) *	2001-12-12	2008-01-01	Aaron Pearse	Web snippets capture, storage and retrieval system and method
US8129431B2 (en)	2003-01-21	2012-03-06	Senju Pharmaceutical Co., Ltd.	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
KR20120035220A (ko) *	2003-01-22	2012-04-13	센주 세이야꾸 가부시키가이샤	안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
US8748402B2 (en)	2004-06-07	2014-06-10	Bausch & Lomb Pharma Holdings Corp.	Ophthalmic formulations and uses thereof
US8372814B2 (en) *	2004-06-07	2013-02-12	Ista Pharmaceuticals, Inc.	Ophthalmic formulations and uses thereof
US20070208058A1 (en) *	2004-10-25	2007-09-06	Bryant Roy W	Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20100160293A1 (en) *	2005-02-17	2010-06-24	Kakuji Tojo	Solid Ophthalmic Drug for External Use
HUE033597T2 (hu)	2006-09-29	2017-12-28	Johnson & Johnson Vision Care	Eljárás allergia elleni szert tartalmazó szemészeti eszköz oxidációjának megelõzésére
EP2155162B1 (fr) *	2007-05-04	2012-11-21	Bausch & Lomb Incorporated	Compositions pour réduire, améliorer, traiter, ou empêcher l'affection de kératoconjonctivite sèche, et leurs procédés de fabrication et d'utilisation
WO2008137826A2 (fr) *	2007-05-07	2008-11-13	Bausch & Lomb Incorporated	Compositions pour réduire, améliorer, traiter, ou prévenir la kératoconjonctivite et procédés pour leur fabrication et utilisation
US8300252B2 (en) *	2008-06-18	2012-10-30	Livescribe, Inc.	Managing objects with varying and repeated printed positioning information
TW201023912A (en) *	2008-12-05	2010-07-01	Alcon Res Ltd	Pharmaceutical suspension
WO2010101989A1 (fr) *	2009-03-03	2010-09-10	Alcon Research, Ltd.	Composition pharmaceutique pour l'administration à l'oeil de composés inhibant les récepteurs tyrosine kinase (rtki)
AU2010221438C1 (en) *	2009-03-03	2015-01-29	Alcon Research, Ltd.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
SG11201507316UA (en) *	2013-03-14	2015-10-29	Panoptica Inc	Ocular formulations for drug-delivery to the posterior segment of the eye
US10383885B2 (en)	2015-06-16	2019-08-20	Rong-Tsun Wu	Method for treating or preventing dry eyes
JP2020525416A (ja) *	2017-06-29	2020-08-27	アドヴァイテエルエルシー．	眼表面障害の治療及び診断

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340191C (fr)	1988-06-13	1998-12-15	Katsuhiro Imaki	Derives d'ester phenylique de l'acide pivalique, avec substitution en p
JPH0320253A (ja) *	1988-06-13	1991-01-29	Ono Pharmaceut Co Ltd	ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
WO1990004409A1 (fr) *	1988-10-27	1990-05-03	University Of Kentucky Research Foundation	Inhibiteurs de l'elastase de leucocytes humains, leurs procedes de production et d'utilisation
DE69223455T2 (de)	1991-06-18	1998-04-02	Fujisawa Pharmaceutical Co	WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
GB9115811D0 (en)	1991-07-22	1991-09-04	Fujisawa Pharmaceutical Co	Fr901451 substance,process for preparation thereof and use thereof
JPH05194366A (ja) *	1991-10-25	1993-08-03	Ono Pharmaceut Co Ltd	グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
EP0539223A1 (fr)	1991-10-25	1993-04-28	Ono Pharmaceutical Co., Ltd.	Tétrahydrate d'un sel monosodique d'un dérivé de glycine ayant un effet inhibiteur sur l'élastase

2000
- 2000-09-05 AU AU68708/00A patent/AU6870800A/en not_active Abandoned
- 2000-09-05 BR BR0013793-6A patent/BR0013793A/pt not_active IP Right Cessation
- 2000-09-05 WO PCT/JP2000/006014 patent/WO2001017527A1/fr not_active Ceased
- 2000-09-05 MX MXPA02002452A patent/MXPA02002452A/es unknown
- 2000-09-05 NZ NZ517556A patent/NZ517556A/en unknown
- 2000-09-05 CA CA002383971A patent/CA2383971A1/fr not_active Abandoned
- 2000-09-05 KR KR1020027002991A patent/KR20020042667A/ko not_active Withdrawn
- 2000-09-05 EP EP00956927A patent/EP1213018A4/fr not_active Withdrawn
- 2000-09-05 JP JP2001521318A patent/JP4682495B2/ja not_active Expired - Fee Related
- 2000-09-05 HU HU0202745A patent/HUP0202745A2/hu unknown
- 2000-09-05 CN CN00815442A patent/CN1387436A/zh active Pending
- 2000-09-05 US US10/070,307 patent/US6624193B1/en not_active Expired - Fee Related
2002
- 2002-03-05 NO NO20021094A patent/NO20021094L/no not_active Application Discontinuation
- 2002-03-05 ZA ZA200201819A patent/ZA200201819B/xx unknown

Also Published As

Publication number	Publication date
US6624193B1 (en)	2003-09-23
EP1213018A1 (fr)	2002-06-12
EP1213018A4 (fr)	2004-04-14
AU6870800A (en)	2001-04-10
BR0013793A (pt)	2002-05-14
CA2383971A1 (fr)	2001-03-15
MXPA02002452A (es)	2004-09-10
CN1387436A (zh)	2002-12-25
WO2001017527A1 (fr)	2001-03-15
NO20021094D0 (no)	2002-03-05
WO2001017527A9 (fr)	2001-06-21
JP4682495B2 (ja)	2011-05-11
HUP0202745A2 (hu)	2003-01-28
NZ517556A (en)	2003-08-29
KR20020042667A (ko)	2002-06-05
NO20021094L (no)	2002-05-06

Publication	Publication Date	Title
GB9911863D0 (en)	1999-07-21	Therapeutic agents
GB9905010D0 (en)	1999-04-28	Therapeutic agents
ZA200201819B (en)	2003-05-28	Preventive and therapeutic agents for eye diseases.
IL150030A0 (en)	2002-12-01	Therapeutic agents
GB9904786D0 (en)	1999-04-28	Therapeutic agents
GB9929685D0 (en)	2000-02-09	Therapeutic agents
GB9929687D0 (en)	2000-02-09	Therapeutic agents
GB9921351D0 (en)	1999-11-10	Therapeutic agents
GB9911881D0 (en)	1999-07-21	Therapeutic agents
ZA200003768B (en)	2002-03-27	Methods and compositions for treating diseases and conditions of the eye.
MXPA03003741A (es)	2003-07-28	Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
GB9903476D0 (en)	1999-04-07	Therapeutic agents
PL339848A1 (en)	2000-10-23	Therapeutic agent against hypephosphataemia
GB9929569D0 (en)	2000-02-09	Therapeutic agents
GB9914745D0 (en)	1999-08-25	Therapeutic agents
GB9914744D0 (en)	1999-08-25	Therapeutic agents
GB9903119D0 (en)	1999-04-07	Therapeutic agents
ZA200110046B (en)	2003-03-06	Therapeutic agents.
GB9902881D0 (en)	1999-03-31	Therapeutic agents
PL352681A1 (en)	2003-09-08	Preventive and therapeutic agents for cancer
EP0925791A4 (fr)	2004-06-16	Agent preventif et/ou therapeutique pour les maladies des reins
GB9914743D0 (en)	1999-08-25	Therapeutic agents
GB9915616D0 (en)	1999-09-01	Therapeutic agents
AU2001230589A1 (en)	2001-08-20	Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases
GB9915617D0 (en)	1999-09-01	Therapeutic agents